4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-23-047102
President and CEO sold 5,210 shares at $16.66 ($86,779)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fordyce Marshall President and CEO | 2023-08-21 | Sale 10b5-1 | −5,210 | $16.66 | $86,779 | 243,361 | D: show line 1 in the form |
| Open-market sales · 5,210 sh · avg $16.66 · $86,779 | |||||||
Loading xslF345X05/doc4.xml…